About Expansion Therapeutics
Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The company’s initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options. Expansion is based in Jupiter, Florida
|
|
|
11-50 employees
View all Expansion Therapeutics employees
|
|
Biotechnology
|
|
555 Heritage Dr, Suite 150, Jupiter, Florida 33458, US
|
|
2016
|
|
Small Molecules, Expansion Repeats, Rna Mediated Disease
|
Expansion Therapeutics Alternatives
Frequently Asked Questions about Expansion Therapeutics
Renato Skerlj is the CEO of Expansion Therapeutics. To contact Renato Skerlj email at [email protected], [email protected] or [email protected].
The decision makers in Expansion Therapeutics are Andrew Good, Jennifer Visco, Mark Fielden, etc. Click to Find Expansion Therapeutics decision makers emails.
Expansion Therapeutics Staff Directory
Search Expansion Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
